- Differential Diagnosis
Drug Information for MEPERIDINE HYDROCHLORIDE Tablets USPMEPERIDINE HYDROCHLORIDE Oral Solution USP (Boehringer Ingelheim): ADVERSE REACTIONS
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DRUG ABUSE AND DEPENDENCE
- SAFETY AND HANDLING
- HOW SUPPLIED
- External Links Related to MEPERIDINE HYDROCHLORIDE Tablets USPMEPERIDINE HYDROCHLORIDE Oral Solution USP (Boehringer Ingelheim)
The major hazards of meperidine, as with other narcotic analgesics, are respiratory depression and, to a lesser degree, circulatory depression; respiratory arrest, shock, and cardiac arrest have occurred.
The most frequently observed adverse reactions include lightheadedness, dizziness, sedation, nausea, vomiting, and sweating. These effects seem to be more prominent in ambulatory patients and in those who are not experiencing severe pain. In such individuals, lower doses are advisable. Some adverse reactions in ambulatory patients may be alleviated if the patient lies down.
Other adverse reactions include:
Euphoria, dysphoria, weakness, headache, agitation, tremor, uncoordinated muscle movements, (e.g., muscle twitches, myoclonus), severe convulsions, transient hallucinations and disorientation, visual disturbances.
Dry mouth, constipation, biliary tract spasm.
Flushing of the face, tachycardia, bradycardia, palpitation, hypotension (see WARNINGS), syncope.
Pruritus, urticaria, other skin rashes, wheal and flare over the vein with intravenous injection.
- Drug Information Provided by National Library of Medicine (NLM).